-
-
-
-
-
-
-
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
-
-
-
-
-
-
-
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
-
-
-
-
-
-
-
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
-
-
-
-
-
-
-
Form F-1/A Optimi Health Corp.
-
-
-
-
-
-
-
Form F-1 Optimi Health Corp.
-
16,330 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

